DarioHealth and HMC HealthWorks Announce Partnership Agreement
Agreement extends DarioHealth's reach into HMC's vast multi-employer welfare fund and employer client base through which HMC is currently managing more than one million members
Sep 21, 2020
NEW YORK and JUPITER, Fla., Sept. 21, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, and HMC HealthWorks, a 40-year veteran in healthcare management with clinically-integrated models of care that reduce healthcare costs and improve population health, today announced that the companies have entered into a sales and distribution partnership pursuant to which HMC will incorporate DarioHealth's digital therapeutics solution into its comprehensive care management programs. HMC will offer DarioHealth's platform on both a stand-alone basis as well as incorporated into HMC's comprehensive care management solutions.
"We believe that this agreement with HMC is further validation of the progress we have made in transitioning to a leading provider of digital therapeutics solutions to payors, employers and other at risk entities with a desire to help their members manage their chronic conditions and improve their clinical outcomes," stated Rick Anderson, President and General Manager of North America at DarioHealth. "We are pleased to partner with HMC, who has a long history of providing innovative solutions to their customers. This agreement expands our distribution of our solutions and we are already building a pipeline within HMC's vast client base, which we believe speaks to the tangible results that we bring to patients and payers alike."
"At HMC, we believe that behavior change is key to driving better participant health and well-being," noted Janice Dimonaco, Chief Executive Officer of HMC HealthWorks. "Our approach takes a holistic view of the member and integrates the very latest in technology and data analytics to provide the support and positive reinforcement that can lead to long-term success. We rigorously evaluated several different platforms and determined that Dario is offering the most innovative, unique digital technology in the space, and the ease of implementation will be a significant benefit to our customers. We look forward to a long and mutually beneficial partnership."
About HMC HealthWorks
HMC HealthWorks, the premier national provider of population healthcare management programs, offers plan sponsors value-added programs including Integrated Clinical Solutions, Chronic Care Management, Behavioral Health Solutions, Wellness/Lifestyle Coaching and Care Coordination- www.hmchealthworks.com.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. (the "Company") related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" are intended to identify forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses that the agreement with HMC is further validation of the progress it has made in transitioning to a leading provider of digital therapeutics solutions to payors, employers and other at risk entities with a desire to help their members manage their chronic conditions and improve their clinical outcomes, that it is already building a pipeline within HMC's vast client base, which it believes speaks to the tangible results that it brings to patients and payers alike and that HMC has determined that the Company is offering the most innovative, unique digital technology in the space, and the ease of implementation will be a significant benefit to HMC's customers. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
DarioHealth Corporate Contact:
Content & Communications Manager
Investor Relations Contact:
SOURCE DarioHealth Corp.